Skip to content
10-Q

Quarterly Report

AXSOME THERAPEUTICS, INC. AXSM

0001193125-25-262664

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 27, 2025 50.41M sh
Shares Diluted Q3 2025 · Sep 30, 2025 50.02M sh
Shares Diluted Q3 2025 · Sep 30, 2025 49.45M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.14M sh
Shares Diluted Q3 2025 · Sep 30, 2024 47.7M sh
Capex Q3 2025 · Sep 30, 2025 $409K
Capex Q3 2025 · Sep 30, 2024 $240K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$74.75M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$102.21M
Long Term Debt Q3 2025 · Sep 30, 2025 $117.64M
Long Term Debt Q3 2025 · Dec 31, 2024 $180.71M
Short Term Debt Q3 2025 · Sep 30, 2025 $70M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $325.27M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $315.35M
Stockholders Equity Q3 2025 · Sep 30, 2025 $73.73M
Stockholders Equity Q3 2025 · Jun 30, 2025 $73.08M
Stockholders Equity Q3 2025 · Mar 31, 2025 $53.21M
Stockholders Equity Q3 2025 · Dec 31, 2024 $57.02M
Stockholders Equity Q3 2025 · Sep 30, 2024 $92.9M
Stockholders Equity Q3 2025 · Jun 30, 2024 $102.85M
Stockholders Equity Q3 2025 · Mar 31, 2024 $144.04M
Stockholders Equity Q3 2025 · Dec 31, 2023 $190.98M
Current Liabilities Q3 2025 · Sep 30, 2025 $360.29M
Current Liabilities Q3 2025 · Dec 31, 2024 $230.1M
Total Liabilities Q3 2025 · Sep 30, 2025 $595.52M
Total Liabilities Q3 2025 · Dec 31, 2024 $511.48M
Current Assets Q3 2025 · Sep 30, 2025 $565.34M
Current Assets Q3 2025 · Dec 31, 2024 $485.06M
Total Assets Q3 2025 · Sep 30, 2025 $669.25M
Total Assets Q3 2025 · Dec 31, 2024 $568.5M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.94
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.34
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.45
Eps Basic Q3 2025 · Sep 30, 2025 −$0.94
Eps Basic Q3 2025 · Sep 30, 2025 −$3.13
Eps Basic Q3 2025 · Sep 30, 2024 −$1.34
Eps Basic Q3 2025 · Sep 30, 2024 −$4.45
Sga Expense Q3 2025 · Sep 30, 2025 $150.24M
Sga Expense Q3 2025 · Sep 30, 2025 $401.3M
Sga Expense Q3 2025 · Sep 30, 2024 $95.56M
Sga Expense Q3 2025 · Sep 30, 2024 $298.09M
Rd Expense Q3 2025 · Sep 30, 2025 $40.16M
Rd Expense Q3 2025 · Sep 30, 2025 $134.49M
Rd Expense Q3 2025 · Sep 30, 2024 $45.39M
Rd Expense Q3 2025 · Sep 30, 2024 $132.07M
Net Income Q3 2025 · Sep 30, 2025 −$47.23M
Net Income Q3 2025 · Sep 30, 2025 −$154.62M
Net Income Q3 2025 · Jun 30, 2025 −$47.97M
Net Income Q3 2025 · Mar 31, 2025 −$59.41M
Net Income Q3 2025 · Sep 30, 2024 −$64.6M
Net Income Q3 2025 · Sep 30, 2024 −$212.3M
Net Income Q3 2025 · Jun 30, 2024 −$79.35M
Net Income Q3 2025 · Mar 31, 2024 −$68.36M
Operating Income Q3 2025 · Sep 30, 2025 −$46.11M
Operating Income Q3 2025 · Sep 30, 2025 −$139.81M
Operating Income Q3 2025 · Sep 30, 2024 −$62.62M
Operating Income Q3 2025 · Sep 30, 2024 −$207.95M
Revenue Q3 2025 · Sep 30, 2025 $170.99M
Revenue Q3 2025 · Sep 30, 2025 $442.5M
Revenue Q3 2025 · Sep 30, 2024 $104.76M
Revenue Q3 2025 · Sep 30, 2024 $266.93M